Collegium Pharmaceutical, Inc. (COLL)
35.81
-0.80
(-2.19%)
USD |
NASDAQ |
Mar 11, 13:32
Collegium Pharmaceutical Shareholders Equity (Quarterly) : 301.68M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 647.80M |
| Johnson & Johnson | 81.54B |
| Rigel Pharmaceuticals, Inc. | 391.48M |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| Axsome Therapeutics, Inc. | 88.30M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.686B |
| Total Liabilities (Quarterly) | 1.384B |
| Debt to Equity Ratio | 3.104 |
| Current Ratio | 1.571 |
| Net Debt Paydown Yield | 0.77% |